# Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor

> **NCT00848172** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 29 (actual)

## Conditions studied

- Essential Tremor

## Interventions

- **DRUG:** Octanoic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00848172
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2012-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00848172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00848172, "Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00848172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*